{"entity":{"id":"zhuhai-yufan-biotechnologies","kind":"company","name":"Zhuhai Yufan Biotechnologies","aka":["Zhuhai Yufan Biotechnologies Co., Ltd"],"tldr":"Zhuhai Yufan Biotechnologies is a Chinese developer in Zhuhai that sponsors 2 registered cancer trials of PRJ1-3024.","summary":"Zhuhai Yufan Biotechnologies appears on ClinicalTrials.gov as the industry sponsor of 2 interventional cancer trials (phase 1/2), testing PRJ1-3024 in melanoma, advanced solid tumor, advanced solid malignancies. OnCo records the company from the registry alone: the head office city comes from its registered name, and there are no website, funding or approval claims until they are sourced.","asOf":"2026-09-11","links":[{"label":"ClinicalTrials.gov: trials sponsored by Zhuhai Yufan Biotechnologies","url":"https://clinicaltrials.gov/search?spons=Zhuhai%20Yufan%20Biotechnologies"}],"tags":["ctgov-sponsor","china","registry-only"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":["nct06727630","nct05315167"],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"hq":"Zhuhai, China","country":"CN","companyType":"biotech","investors":[],"funding":[]},"route":"/companies/zhuhai-yufan-biotechnologies/","neighbours":{"trial":[{"id":"nct05315167","kind":"trial","name":"A Phase I/II Study to Evaluate the Safety, Pharmacokinetics and Efficacy of PRJ1-3024 in Subjects with Advanced Solid Tumors","route":"/trials/nct05315167/"},{"id":"nct06727630","kind":"trial","name":"A Phase Ib Study of PRJ1-3024 for Treatment of Advanced or Metastatic Melanoma","route":"/trials/nct06727630/"}]}}